TABLE 1

Patient Data

ParameterValue for patient:Mean ± SDMedian
P1P2P3P4P5P6
Patient age (y)57374632453242 ± 1041
Patient height (cm)170165165179174188174 ± 9172
Patient weight (kg)70645496648873 ± 1667
BMI (kg/m2)24.223.519.830.021.124.923.9 ± 3.523.9
TNM stage (UICC 1997)3/0/02/0/04/0/02/0/02/0/02/0/0
Time to THST (d)53645NA4.6 ± 1.15.0
Time between surgery and first diagnostic course (d)929567681053677 ± 2580
TSH baseline (mU/L)0.10.10.10.10.10.4
rhTSH regimen (no. of doses)232232
TSH at first diagnostic course (mU/L)>80>80>80>80>80>80
Tg at first diagnostic course (ng/mL)1.84.01.10.44.43.52.5 ± 1.62.6
Time between first and second diagnostic courses (d)37303535444237 ± 536
TSH at second diagnostic course (mU/L)26>80>80>80>80>80
Tg at second diagnostic course (ng/mL)3.4162.70.43.70.54.5 ± 5.83.1
Time between second diagnostic course and therapy (d)97787128.3 ± 2.07.5
TSH at therapy (mU/L)42>80>80>80>80>80
Tg at therapy (ng/mL)4.57.22.70.42.90.83.1 ± 2.52.8
Therapeutic activity (GBq)3.13.273.713.563.073.853.43 ± 0.333.42
Outcome (at 6 mo follow-up)CR131I+CRCRCR131I+
  • BMI = body mass index; Tg = thyroglobulin; NA = not applicable; CR = complete remission (Tg level < 0.2 ng/mL; no evidence of pathologic 131I uptake in subsequent diagnostic scans; UICC 1997 = International Union Against Cancer, 5th edition); 131I+ = 131I-positive scan.